FDA WARNING_LETTER - Bee Delightful - December 22, 2020

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Bee Delightful

Record Details

On December 22, 2020, the FDA issued a Warning Letter to Skyler R. Johnstone, owner of Bee Delightful, following an October 2020 review of their websites, www.beedelightful.com and www.facebook.com/BeeDelightfulUSA. The FDA determined that the company sells "Canna Bees Rescue Blend" products containing cannabidiol (CBD) with unapproved drug claims, including those related to mitigating, preventing, treating, diagnosing, or curing COVID-19.

The "Canna Bees Rescue Blend" products are deemed unapproved new drugs under sections 505(a) and 301(d) of the FD&C Act (21 U.S.C. 355(a) and 331(d)) because they are promoted with therapeutic claims (e.g., "Helps fight depression," "reduce the virus receptors by 73%"). They are also misbranded under section 502(f)(1) (21 U.S.C. 352(f)(1)) due to a lack of adequate directions for use, as the conditions they claim to treat are not amenable to self-diagnosis.

Furthermore, the products are adulterated under section 402(a)(2)(C)(i) (21 U.S.C. § 342

Company: Bee Delightful
Inspection Date: December 22, 2020
Product Type: Food
Office: Division of Human and Animal Food Operations - West III
People: Edmundo Garcia (Program Director)
Lori Woznicki (Director)

Open in Dashboard

ID · a287fdbd-0829-451d-add5-88f560fad6ac

Violation Codes10

21.U.S.C. 355(a)21 U.S.C. 331(d)21 U.S.C. 352(f)(1)21 U.S.C. 342(a)(2)(C)(i)21 U.S.C. 331(ll)21 U.S.C. 321(g)(1)21 U.S.C. 321(p)21 U.S.C. 348(a)21 CFR 201.521 CFR 201.100(c)(2)

Full citation text and observation details available on the Dashboard.